Lithium carbonate
Brand names: Priadel, Camcolit, Liskonum
Lithium carbonate is a mood stabiliser used for the treatment and prophylaxis of bipolar disorder and mania and as augmentation in resistant depression.
ClinCalc Pro is rebuilding its dose data from primary open sources — the manufacturer SmPC (eMC), the WHO Model Formulary and other official references — under clinician review. This drug's structured dose is not yet published here. Confirm all doses against the product SmPC and your local formulary before prescribing.
Clinical monograph
How it works
Its mood-stabilising action is incompletely understood but involves modulation of second-messenger systems, including effects on inositol monophosphatase and glycogen synthase kinase-3 signalling.
Prescribing in practice
- Lithium has a narrow therapeutic index and serum levels must be monitored, with toxicity precipitated by dehydration, renal impairment, sodium depletion, NSAIDs, diuretics and ACE inhibitors; brands are not interchangeable.
- Long-term use can impair renal and thyroid function and cause hypercalcaemia, so check renal, thyroid and calcium status before and periodically during treatment.
- Recognise toxicity (tremor, vomiting, diarrhoea, ataxia, confusion, seizures) as a medical emergency and counsel on maintaining fluid and salt intake and avoiding interacting medicines.
Monitoring
Monitor serum lithium levels regularly, with periodic renal function, thyroid function and calcium, more often after dose changes or intercurrent illness.
Counselling the patient
- Maintain steady fluid and salt intake and seek advice during vomiting, diarrhoea or fever.
- Carry a lithium record, take blood tests as scheduled, and avoid over-the-counter anti-inflammatory painkillers unless approved.
- Report tremor, drowsiness, slurred speech or vomiting urgently as signs of toxicity.
Evidence & guidelines
NICE bipolar disorder guidance recommends lithium as a first-line long-term treatment with defined serum-level and organ-function monitoring.
Reference: NICE CG185; NPSA Patient Safety Alert; Drug verified in RxNorm (NLM); confirm dosing against the manufacturer SPC (eMC). Verify against your local formulary and current prescribing references before prescribing. Monograph status: clinician-reviewed (2026-07-04).
Related
Curated clinical cross-links plus same-class fallbacks.